Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0001815
Disease: Primary Myelofibrosis
Primary Myelofibrosis
0.010 AlteredExpression disease BEFREE BM from PMF expressed a noncanonical transforming growth factor β (TGF-β) signature, which included activation of ID1, JUN, GADD45b, and genes with binding motifs for the JUN transcriptional complex AP1. 31678370 2019
CUI: C0007131
Disease: Non-Small Cell Lung Carcinoma
Non-Small Cell Lung Carcinoma
0.010 Biomarker disease BEFREE This study indicates that GADD45B and PMAIP1 could be promising tumor suppressors for NSCLC and might be useful as prognostic markers for use in NSCLC therapy. 31296259 2019
CUI: C0007785
Disease: Cerebral Infarction
Cerebral Infarction
0.010 Biomarker disease BEFREE Our results suggested that the ALK5 signaling pathway plays a critical role in mediating neural plasticity and neurological function recovery via Gadd45b after cerebral ischemia, representing a new potential target for cerebral I/R injury. 31043581 2019
CUI: C0024141
Disease: Lupus Erythematosus, Systemic
Lupus Erythematosus, Systemic
0.010 GeneticVariation disease BEFREE In clinical manifestation, the odds ratio of GADD45b -712CT genotype with anti-RNP antibody was 4.14 (95% CI, 1.10-15.63) in SLE patients. 31195707 2019
CUI: C0025322
Disease: Premature Menopause
Premature Menopause
0.010 AlteredExpression disease BEFREE However, MB-MSCs combined with BSTCR rescued epirubicin induced POF through down-regulating GADD45b and pCDC2 expressions, and up-regulating CyclinB1 and CDC2 expressions. 31311554 2019
CUI: C0033300
Disease: Progeria
Progeria
0.010 AlteredExpression disease BEFREE Inhibition of progerin production in cells of aged non-HGPS donors <i>in vivo</i> increases the proliferative activity, H3K9me3, and HP1, and decreases the senescence markers p21, IGFBP3, and GADD45B to the levels of young donor cells. 31156709 2019
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.010 Biomarker group BEFREE In our previous studies, growth arrest and DNA damage protein 45b (Gadd45b) mediated axonal plasticity after stroke. 31043581 2019
CUI: C0040100
Disease: Thymoma
Thymoma
0.010 AlteredExpression disease BEFREE Real-time PCR analysis confirmed that CCL25 was upregulated; and MYC, GADD45B, TNFRSF12 downregulated in thymoma with MG. Our study thus provided important genetic information on thymoma. 30787364 2019
CUI: C0085215
Disease: Ovarian Failure, Premature
Ovarian Failure, Premature
0.010 AlteredExpression disease BEFREE However, MB-MSCs combined with BSTCR rescued epirubicin induced POF through down-regulating GADD45b and pCDC2 expressions, and up-regulating CyclinB1 and CDC2 expressions. 31311554 2019
CUI: C0677060
Disease: essential thrombocytopenia
essential thrombocytopenia
0.010 AlteredExpression disease BEFREE By contrast, the expression of ID1 and GADD45b was not altered and there was a modest signal for JUN activation in ET. 31678370 2019
CUI: C0871388
Disease: social stress
social stress
0.010 Biomarker disease BEFREE Together, these data suggest that Gadd45b in NAc contributes to susceptibility to social stress. 30874581 2019
CUI: C0023473
Disease: Myeloid Leukemia, Chronic
Myeloid Leukemia, Chronic
0.010 Biomarker disease BEFREE BCR-ABL Gadd45b deficient CML progenitors exhibited increased proliferation and decreased apoptosis, associated with hyper-activation of c-Jun NH<sub>2</sub>-terminal kinase and Stat5. 30279966 2018
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.010 AlteredExpression phenotype BEFREE The immunohistochemical analysis of Gadd45β expression revealed that 75% of histological specimens from patients with CCA expressed high levels of Gadd45β, and that high Gadd45β expression was associated with metastasis. 29435034 2018
CUI: C0206698
Disease: Cholangiocarcinoma
Cholangiocarcinoma
0.010 Biomarker disease BEFREE The role of Gadd45β in CCA was examined using siRNA-mediated gene knockdown in HuCCA-1, a human CCA cell line established from a Thai patient. 29435034 2018
Congenital contractural arachnodactyly
0.010 Biomarker disease BEFREE The role of Gadd45β in CCA was examined using siRNA-mediated gene knockdown in HuCCA-1, a human CCA cell line established from a Thai patient. 29435034 2018
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate
0.010 AlteredExpression disease BEFREE Matrine may be used to treat prostate cancer patients to increase the levels of GADD45B to inhibit tumor invasion and improve patient survivals. 29356020 2018
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.010 AlteredExpression disease BEFREE Matrine may be used to treat prostate cancer patients to increase the levels of GADD45B to inhibit tumor invasion and improve patient survivals. 29356020 2018
CUI: C0677948
Disease: Stage II Colorectal Cancer
Stage II Colorectal Cancer
0.010 Biomarker disease BEFREE GADD45B as a Prognostic and Predictive Biomarker in Stage II Colorectal Cancer. 30029519 2018
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.010 AlteredExpression phenotype BEFREE Matrine may be used to treat prostate cancer patients to increase the levels of GADD45B to inhibit tumor invasion and improve patient survivals. 29356020 2018
CUI: C1739135
Disease: Progression of prostate cancer
Progression of prostate cancer
0.010 AlteredExpression disease BEFREE Matrine inhibits the progression of prostate cancer by promoting expression of GADD45B. 29356020 2018
CUI: C3146252
Disease: Stage II Colorectal Cancer AJCC v7
Stage II Colorectal Cancer AJCC v7
0.010 Biomarker disease BEFREE GADD45B as a Prognostic and Predictive Biomarker in Stage II Colorectal Cancer. 30029519 2018
CUI: C0036220
Disease: Kaposi Sarcoma
Kaposi Sarcoma
0.010 Biomarker disease BEFREE Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs Target GADD45B To Protect Infected Cells from Cell Cycle Arrest and Apoptosis. 27852859 2017
CUI: C0242379
Disease: Malignant neoplasm of lung
Malignant neoplasm of lung
0.010 GeneticVariation disease BEFREE MDR (multifactor dimensionality reduction) analyses showed that smoking history as main effect and three-way models (smoking duration, 19p13.3-GADD45B rs3783501, 19q13.3-CD3EAP rs967591) (P = 0.001-0.002) indicated statistically significant association with lung cancer risk. 28870783 2017
CUI: C0424166
Disease: Social Anxiety
Social Anxiety
0.010 GeneticVariation disease BEFREE In this context, we investigated the effects of chronic social defeat stress (CSDS) on anxiety-, social- and cognitive-related behaviors, as well as hippocampal Bdnf, synaptic plasticity markers (PSD-95, Synaptophysin, Spinophilin, Synapsin I and MAP-2), and epigenetic modifying enzymes (MYST2, HDAC2, HDAC6, MLL3, KDM5B, DNMT3B, GADD45B) gene expression in C57BL/6J mice. 28374847 2017
CUI: C0684249
Disease: Carcinoma of lung
Carcinoma of lung
0.010 GeneticVariation disease BEFREE MDR (multifactor dimensionality reduction) analyses showed that smoking history as main effect and three-way models (smoking duration, 19p13.3-GADD45B rs3783501, 19q13.3-CD3EAP rs967591) (P = 0.001-0.002) indicated statistically significant association with lung cancer risk. 28870783 2017